Analyst firms · Citigroup · AGL
Citigroup AGL price target and rating history
agilon health inc. (AGL) · Health Care
Citigroup rates agilon health inc. (AGL) Neutral with a $115 price target, as of its latest action on Aug 11, 2026. It has published 7 rating actions on AGL since April 2024, including 3 upgrades and 3 downgrades. Across 5 firms with a AGL price target in the last 12 months, the median target is $81. Citigroup's $115 is 42% above that.
- Current rating
- Neutral
- Price target
- $115
- Median target, all firms
- $81
- Actions on AGL
- 7
Citigroup price target on AGL
Every Citigroup rating on AGL
- Aug 11, 2026
- Jul 23, 2026
- Aug 6, 2025
- Apr 25, 2025
- Jan 10, 2025
- Oct 30, 2024
- Apr 22, 2024
How other firms rate AGL
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Bernstein | Outperform | $125 | Sep 15, 2026 |
| Citigroup | Neutral | $115 | Aug 11, 2026 |
| Barclays | Equal Weight | $81 | May 26, 2026 |
| Jefferies | Buy | $48 | May 7, 2026 |
| Deutsche Bank | Buy | $49 | May 7, 2026 |
Questions about Citigroup and AGL
- What is Citigroup's price target for AGL?
- Citigroup's latest stated price target for agilon health inc. (AGL) is $115, from its action on Aug 11, 2026.
- What is Citigroup's rating on AGL?
- Citigroup rates AGL Neutral, a neutral rating, as of Aug 11, 2026.
- When did Citigroup last change its view on AGL?
- On Aug 11, 2026, Citigroup upgrades to Neutral from Sell, price target $115.
- How does Citigroup's AGL target compare with other analysts?
- Across 5 firms with a AGL price target in the last 12 months, the median target is $81. Citigroup's $115 is 42% above that.
More AGL rating histories
All Citigroup ratingsAGL news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.